NAVELBINE is indicated as a single agent or in combination with cisplatin for the first-line treatment of ambulatory patients with unresectable, advanced nonsmall cell lung cancer (NSCLC). In patients with Stage IV NSCLC, NAVELBINE is indicated as a single agent or in combination with cisplatin. In Stage III NSCLC, NAVELBINE is indicated in combination with cisplatin.
NAVELBINE Injection is a clear, colorless to pale yellow solution in Water for Injection, containing 10 mg vinorelbine per mL. NAVELBINE Injection is available in single-use, clear glass vials with elastomeric stoppers and royal blue caps, individually packaged in a carton in the following vial sizes: 10 mg/1 mL Single-Use Vial, Carton of 1 (NDC 0173-0656-01). 50 mg/5 mL Single-Use Vial, Carton of 1 (NDC 0173-0656-44).
Store the vials under refrigeration at 2∞ to 8∞C (36∞ to 46∞F) in the carton. Protect from light. DO NOT FREEZE.
Reviews
There are no reviews yet.